Predictors of perioperative morbidity and mortality in patients with Antiphospholipid antibody syndrome (APS) and chronic thromboembolic pulmonary hypertension (CTPEH) after Endarterectomy Pulmonary.
E. Bermudez (CDMX, Mexico), R. Zebadua (CDMX, Mexico), J. Lopez (CDMX, Mexico), M. Pozas (CDMX, Mexico), L. Zorrilla (CDMX, Mexico), T. Pulido (CDMX, Mexico), J. Sandoval (CDMX, Mexico), N. Zayas (CDMX, Mexico)
Source: International Congress 2022 – Pulmonary embolism: acute and long-term management
Session: Pulmonary embolism: acute and long-term management
Session type: Oral Presentation
Number: 3133
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bermudez (CDMX, Mexico), R. Zebadua (CDMX, Mexico), J. Lopez (CDMX, Mexico), M. Pozas (CDMX, Mexico), L. Zorrilla (CDMX, Mexico), T. Pulido (CDMX, Mexico), J. Sandoval (CDMX, Mexico), N. Zayas (CDMX, Mexico). Predictors of perioperative morbidity and mortality in patients with Antiphospholipid antibody syndrome (APS) and chronic thromboembolic pulmonary hypertension (CTPEH) after Endarterectomy Pulmonary.. 3133
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|